Alnylam Pharmaceuticals
ALNY
#584
Rank
โ‚น2.949 T
Marketcap
โ‚น22,977
Share price
-0.89%
Change (1 day)
57.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚น2.949 Trillion

As of September 2024 Alnylam Pharmaceuticals has a market cap of โ‚น2.949 Trillion. This makes Alnylam Pharmaceuticals the world's 584th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚น2.949 T47.51%
2023โ‚น1.999 T-17.35%
2022โ‚น2.419 T60.07%
2021โ‚น1.511 T37.1%
2020โ‚น1.102 T19.87%
2019โ‚น919.69 B79.23%
2018โ‚น513.13 B-36.22%
2017โ‚น804.49 B268.48%
2016โ‚น218.33 B-58.98%
2015โ‚น532.25 B12.31%
2014โ‚น473.92 B87.1%
2013โ‚น253.29 B382.85%
2012โ‚น52.45 B184.77%
2011โ‚น18.42 B-1.58%
2010โ‚น18.71 B-45.49%
2009โ‚น34.33 B-32.56%
2008โ‚น50.91 B8.9%
2007โ‚น46.75 B33.13%
2006โ‚น35.11 B202.91%
2005โ‚น11.59 B104.63%
2004โ‚น5.66 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚น2.949 Trillion
by Yahoo Finance info icon info icon
โ‚น2.949 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.949 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
โ‚น216.92 B-92.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.589 T 258.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.017 T-65.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น85.91 B-97.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.99 B-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.722 T 568.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น12.120 T 310.88%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.664 T-43.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel